Company / Revenue
Revolution Medicines, Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2025
5-year range
$0 / $50.0M
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#147 of 155
Health Care
What the data says
Declined from $12M to $0 over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 155
▼
Key checks
Key Insights
- Peak revenue was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | - |
| FY2024 | $0 | -100.0% |
| FY2023 | $11.6M | -73.1% |
| FY2022 | $43.0M | -14.1% |
| FY2021 | $50.0M | +148.2% |
| FY2020 | $20.2M | -59.7% |
| FY2019 | $50.0M | +148.2% |
| FY2018 | $20.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026